Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Explore this paper's citation graph
Summary
This study conducted a retrospective multicenter study of 68 death cases and 82 discharged cases with laboratory-confirmed infection of SARS-CoV-2 and confirmed that some patients died of fulminant myocarditis, which is characterized by a rapid progress and a severe state of illness.
- Type
- article
- Published
- 2020-03-03
- Cited by
- 4,620
- References
- 3
- Access
- Open access
- OpenAlex
- https://openalex.org/W3009314935
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:211729129
Keywords
Medicine, Anesthesiology, Coronavirus disease 2019 (COVID-19), Pain medicine, China
References
- Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate
Cited by
- Role of computed tomography in predicting critical disease in patients with covid-19 pneumonia: A retrospective study using a semiautomatic quantitative method
- Novel Use of Home Pulse Oximetry Monitoring in COVID‐19 Patients Discharged From the Emergency Department Identifies Need for Hospitalization
- Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study
- Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
- Factors for success of awake prone positioning in patients with COVID-19-induced acute hypoxemic respiratory failure: analysis of a randomized controlled trial
- The Characteristics and Effectiveness of Interventions for Frequent Emergency Department Utilizing Patients With Chronic Noncancer Pain: A Systematic Review
- Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis
- Where are we now with COVID‐19?
- Clinical considerations for patients with diabetes in times of COVID-19 epidemic
- SARS-CoV-2 and COVID-19: facing the pandemic together as citizens and cardiovascular practitioners.
- „Coronavirus disease 2019“ (COVID-19): update für Anästhesisten und Intensivmediziner März 2020
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
- COVID-19, ECMO, and lymphopenia: a word of caution
- COVID‐19 and rationally layered social distancing
- SARS‐CoV‐2, the Virus that Causes COVID‐19: Cytometry and the New Challenge for Global Health
- Effect of continuous renal replacement therapy on all-cause mortality in COVID-19 patients undergoing invasive mechanical ventilation: a retrospective cohort study
- Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
- Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation
- COVID-19: consider cytokine storm syndromes and immunosuppression
Related papers
- [Agreements between surgery and anesthesiology specialties on the exact definition of duties and the cooperation in intensive medicine].
- Book Review: Pain Medicine: The Requisites in Anesthesiology.
- Methadone: applications in pediatric anesthesiology and critical care medicine
- [Pain and anesthesiology].
- Confirmation of SARS-CoV-2 airborne dissemination indoors using “COVID-19 traps”
- Fachinformationen zu SARS-CoV-2/COVID-19
- And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan
- Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management.
- Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV)